Cars.com
CARS
New Fortress Energy
NFE
Teradata Corp
TDC
SilverCrest Metals
SILV
DexCom
DXCM
US Stock MarketDetailed Quotes
NGNE Neurogene
- 18.540
- +0.650+3.63%
Close Jan 15 16:00 ET
275.41MMarket Cap-6.55P/E (TTM)
19.140High18.145Low85.44KVolume18.590Open17.890Pre Close1.58MTurnover1.59%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High2.00P/B99.61MFloat Cap14.44052wk Low--Dividend TTM5.37MShs Float1115.000Historical High--Div YieldTTM5.56%Amplitude7.500Historical Low18.549Avg Price1Lot Size
About Neurogene Company
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Company Profile
SymbolNGNE
Company NameNeurogene
Listing DateMar 7, 2014
Founded2007
CEOMr. Richard K. Matros
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address535 West 24th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10011
Phone1-877-237-5020
Websitehttp://www.neurogene.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel McMinn, PhD
- Executive Chairman of the Board and Chief Executive Officer
- 1.08M
- Dr. Stuart Cobb, PhD
- Chief Scientific Officer
- 784.32K
- Christine Mikail Cvijic, J.D.
- President and Chief Financial Officer
- 1.13M
- Dr. Julie Jordan, M.D.
- Chief Medical Officer
- --
- Donna Cochener
- Senior Vice President and General Counsel
- --
- Dr. Sarah B. Noonberg, M.D.,PhD
- Independent Director
- 62.12K
- Dr. Cory Freedland, PhD
- Independent Director
- --
- Rohan Palekar
- Independent Director
- 71.62K
- Robert Keith Woods
- Independent Director
- --
- Dr. Robert A. Baffi,PhD
- Independent Director
- 64.08K